Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meclizine pharmacokinetics and safety study in pediatric achondroplasia
jRCT2041200114Completed
- Start
- Apr 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of meclizine in achondroplasia (ACH) (2 arms). Primary endpoints: Incidence of adverse events and Pharmacokinetic parameters. Started Apr 2021; status: completed.
02
Drugs
meclizine
03
Conditions
achondroplasia (ACH)
Beyond the preview
Go deeper on jRCT2041200114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2041200114.